Login / Signup

Cost-benefit of outcome adjudication in nine randomised stroke trials.

Peter J GodolphinPhilip M BathAle AlgraEivind BergeJohn ChalmersMisha EliasziwGraeme J HankeyNaohisa HosomiAnnamarei RantaChristian WeimarLisa J WoodhouseAlan A Montgomery
Published in: Clinical trials (London, England) (2020)
Central adjudication is a time-consuming and potentially costly process. These costs need to be considered when designing a trial and should be evaluated alongside the potential benefits adjudication brings to determine whether they outweigh this expense.
Keyphrases
  • clinical trial
  • study protocol
  • open label
  • phase iii
  • atrial fibrillation
  • phase ii
  • double blind
  • placebo controlled
  • human health
  • risk assessment
  • blood brain barrier
  • climate change
  • brain injury